Transcatheter pulmonic regenerative valve

Patent metadata

Field	Value
Publication number	US-11517428-B2
Application number	US-201916666319-A
Country	US
Kind code	B2
Filing date	Oct 28, 2019
Priority date	Nov 1, 2018
Publication date	Dec 6, 2022
Grant date	Dec 6, 2022

Abstract

Artificial heart valves, their manufacture, and methods of use are described. Generally, artificial heart valves can be deployed to replace or supplement defective heart valves in a patient. These artificial heart valves can comprise a frame with an inner skirt and leaflets. These inner skirt and leaflets can be generated from regenerative tissue to allow integration of the tissue with the body of a patient, while the frame can be generated from bioabsorbable material to allow dissolution of the frame over time. This combination of materials may allow for the artificial valve to grow with a patient and avoid costly and potentially dangerous replacement for patients receiving artificial valves.

First claim

What is claimed is:

1. An implantable artificial heart valve comprising:
a frame having a longitudinal axis extending between an inflow end of the frame and an outflow end of the frame, the inflow end of the frame being configured to receive antegrade blood flowing into the prosthetic valve when implanted;
a leaflet structure positioned within the frame and constructed of a regenerative tissue;
an inner skirt positioned around an inner surface of the frame and extending along the longitudinal axis, wherein the inner skirt is constructed of a second regenerative tissue;
wherein the regenerative tissue and the second regenerative tissue are capable of being integrated into native tissue; and
wherein the frame is comprised of a combination of bioabsorbable and non-bioabsorbable materials.

2. The implantable artificial heart valve of claim 1 , wherein the bioabsorbable material is selected from the group consisting of: poly(L-lactide), poly(D-lactide), polyglycolide, poly(L-lactide-co-glycolide), polyhydroxyalkonate, polysaccharides, proteins, polyesters, polyhydroxyalkanoates, polyalkelene esters, polyamides, polycaprolactone, polylactide-co-polycaprolactone, polyvinyl esters, polyamide esters, polyvinyl alcohols, modified derivatives of caprolactone polymers, polytrimethylene carbonate, polyacrylates, polyethylene glycol, hydrogels, photo-curable hydrogels, terminal dials, poly(L-lactide-co-trimethylene carbonate), polyhydroxybutyrate; polyhydroxyvalerate, poly-orthoesters, poly-anhydrides, polyiminocarbonate, and copolymers and combinations thereof.

3. The implantable artificial heart valve of claim 1 , wherein the leaflet structure and inner skirt are constructed of the same regenerative tissue.

4. The implantable artificial heart valve of claim 1 , wherein the frame further comprises a plurality of commissure window frames to allow attachment of the leaflet structure.

5. The implantable artificial heart valve of claim 4 , wherein the commissure window frames are constructed of the non-bioabsorbable material, and at least a portion of the frame is constructed of the bioabsorbable material.

6. The implantable artificial heart valve of claim 1 , wherein the leaflet structure comprises a plurality of leaflets, each leaflet comprising a body portion having a free outflow edge, two opposing upper tabs extending from opposite sides of the body portion, and two opposing lower tabs, each lower tab extending from the body portion adjacent to a respective upper tab, the lower tabs extending from the body portion at opposite ends of the free outflow edge.

7. The implantable artificial heart valve of claim 6 , wherein the lower tabs are folded about radially extending creases that extend radially from the opposite ends of the free outflow edge, such that a first portion of the lower tabs lies flat against the body portion of the respective leaflet, and the lower tabs are folded about axially extending creases such that a second portion of the lower tabs extends in a different plane than the first portion, wherein the radially extending creases and the axially extending creases are non-parallel.

8. The implantable artificial heart valve of claim 6 , wherein the second portion of each lower tab is sutured to a respective upper tab.

9. The implantable artificial heart valve of claim 1 , wherein the frame is radially collapsible to a collapsed configuration and radially expandable to an expanded configuration.

10. The implantable artificial heart valve of claim 1 , wherein the frame further comprises tissue engaging elements to allow fixation of the artificial heart valve to the wall of a blood vessel.

11. The implantable artificial heart valve of claim 10 , wherein the tissue engaging elements include a bioabsorbable glue to prevent the tissue engaging elements from expanding and allowing the artificial heart valve to be repositioned.

12. The implantable artificial heart valve of claim 1 , wherein the regenerative tissue and second regenerative tissue are selected from the group consisting of: polyglactin, collagen, and polyglycolic acid.

13. The implantable artificial heart valve of claim 12 , wherein the regenerative tissue further comprises extracellular matrix proteins selected from the group consisting of: hydroxyproline, vitronectin, fibronectin and collagen type I, collagen type III, collagen type IV, collagen VI, collagen XI, collagen XII, fibrillin I, tenascin, decorin, byglycan, versican, asporin, and combinations thereof.

14. The implantable artificial heart valve of claim 1 , wherein the inner skirt extends beyond at least one of the outflow end and inflow end of the frame and forms an outer skirt attached to an outer surface of the frame.

15. The implantable artificial heart valve of claim 1 , wherein the frame further comprises growth factors to promote integration of the regenerative tissue.

16. The implantable artificial heart valve of claim 1 , wherein an outer diameter of the inflow end portion of the frame is smaller than an outer diameter of the outflow end portion of the frame.

17. The implantable artificial heart valve of claim 1 , wherein the frame has a plurality of openings and portions of the leaflet structure protrude through the openings while the prosthetic valve is in a radially collapsed configuration.

18. The implantable artificial heart valve of claim 1 , wherein the regenerative tissue and second regenerative tissue are decellularized tissue.

19. The implantable artificial heart valve of claim 1 , wherein one or more of the frame, the regenerative tissue, and the second regenerative tissue incorporate a growth factor.

20. The implantable artificial heart valve of claim 19 , wherein the growth factor is selected from the group consisting of: transforming growth factor alpha (TGF-alpha), transforming growth factor beta (TGF-beta), basic fibroblast growth factor (bFGF), vascular epithelial growth factor (VEGF), and combinations thereof.

Assignees

• Edwards Lifesciences Corp

Inventors

• Shang Hao
• Campbell Louis A

Classifications

• A61F2/2436

  Deployment by retracting a sheath · CPC title

• A61F2250/001

  for adjusting a diameter · CPC title

• A61L27/3633

  Extracellular matrix [ECM] · CPC title

• A61F2/2412 Primary

  with soft flexible valve members, e.g. tissue valves shaped like natural valves · CPC title

• A61L2430/20

  for reconstruction of the heart, e.g. heart valves · CPC title